Similar articles for PMID: 16011864

Year	Number of Results
1853	1
1873	1
1876	1
1897	1
1904	1
1906	1
1933	1
1946	1
1948	1
1949	1
1954	1
1957	2
1958	1
1959	1
1960	1
1961	2
1963	1
1968	1
1969	1
1970	2
1972	1
1975	1
1977	1
1979	1
1980	3
1981	2
1982	1
1983	3
1984	3
1985	6
1986	1
1987	1
1988	6
1989	4
1990	1
1991	5
1992	2
1993	3
1994	5
1995	4
1996	7
1997	6
1998	4
1999	8
2000	7
2001	10
2002	10
2003	14
2004	23
2005	35
2006	24
2007	24
2008	33
2009	25
2010	13
2011	16
2012	12
2013	15
2014	12
2015	10
2016	12
2017	3
2018	4
2019	6
2020	4
2021	3
2022	1
2023	2
2024	0

1

Leishmune vaccine blocks the transmission of canine visceral leishmaniasis: absence of Leishmania parasites in blood, skin and lymph nodes of vaccinated exposed dogs.

Nogueira FS, Moreira MA, Borja-Cabrera GP, Santos FN, Menz I, Parra LE, Xu Z, Chu HJ, Palatnik-de-Sousa CB, Luvizotto MC. Nogueira FS, et al. Vaccine. 2005 Sep 23;23(40):4805-10. doi: 10.1016/j.vaccine.2005.05.011. Vaccine. 2005. PMID: 16011864

2

The FML-vaccine (Leishmune) against canine visceral leishmaniasis: a transmission blocking vaccine.

Saraiva EM, de Figueiredo Barbosa A, Santos FN, Borja-Cabrera GP, Nico D, Souza LO, de Oliveira Mendes-Aguiar C, de Souza EP, Fampa P, Parra LE, Menz I, Dias JG Jr, de Oliveira SM, Palatnik-de-Sousa CB. Saraiva EM, et al. Vaccine. 2006 Mar 20;24(13):2423-31. doi: 10.1016/j.vaccine.2005.11.061. Epub 2005 Dec 15. Vaccine. 2006. PMID: 16386824

3

Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.

Lemesre JL, Holzmuller P, Gonçalves RB, Bourdoiseau G, Hugnet C, Cavaleyra M, Papierok G. Lemesre JL, et al. Vaccine. 2007 May 22;25(21):4223-34. doi: 10.1016/j.vaccine.2007.02.083. Epub 2007 Mar 15. Vaccine. 2007. PMID: 17395339 Clinical Trial.

4

Diminished CD4+/CD25+ T cell and increased IFN-gamma levels occur in dogs vaccinated with Leishmune in an endemic area for visceral leishmaniasis.

de Lima VM, Ikeda FA, Rossi CN, Feitosa MM, Vasconcelos RO, Nunes CM, Goto H. de Lima VM, et al. Vet Immunol Immunopathol. 2010 Jun 15;135(3-4):296-302. doi: 10.1016/j.vetimm.2009.12.008. Epub 2010 Jan 21. Vet Immunol Immunopathol. 2010. PMID: 20132994

5

Immunotherapy with the saponin enriched-Leishmune vaccine versus immunochemotherapy in dogs with natural canine visceral leishmaniasis.

Borja-Cabrera GP, Santos FN, Santos FB, Trivellato FA, Kawasaki JK, Costa AC, Castro T, Nogueira FS, Moreira MA, Luvizotto MC, Palatnik M, Palatnik-de-Sousa CB. Borja-Cabrera GP, et al. Vaccine. 2010 Jan 8;28(3):597-603. doi: 10.1016/j.vaccine.2009.09.071. Epub 2009 Oct 1. Vaccine. 2010. PMID: 19800443

6

Immunogenicity of a multicomponent DNA vaccine against visceral leishmaniasis in dogs.

Saldarriaga OA, Travi BL, Park W, Perez LE, Melby PC. Saldarriaga OA, et al. Vaccine. 2006 Mar 10;24(11):1928-40. doi: 10.1016/j.vaccine.2005.10.052. Epub 2005 Nov 9. Vaccine. 2006. PMID: 16310897

7

Decrease of the incidence of human and canine visceral leishmaniasis after dog vaccination with Leishmune in Brazilian endemic areas.

Palatnik-de-Sousa CB, Silva-Antunes I, Morgado Ade A, Menz I, Palatnik M, Lavor C. Palatnik-de-Sousa CB, et al. Vaccine. 2009 Jun 2;27(27):3505-12. doi: 10.1016/j.vaccine.2009.03.045. Epub 2009 Apr 8. Vaccine. 2009. PMID: 19464528 Free article.

8

Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (São Gonçalo do Amarante, RN).

Borja-Cabrera GP, Correia Pontes NN, da Silva VO, Paraguai de Souza E, Santos WR, Gomes EM, Luz KG, Palatnik M, Palatnik de Sousa CB. Borja-Cabrera GP, et al. Vaccine. 2002 Sep 10;20(27-28):3277-84. doi: 10.1016/s0264-410x(02)00294-3. Vaccine. 2002. PMID: 12213397 Clinical Trial.

9

Isotype patterns of immunoglobulins: hallmarks for clinical status and tissue parasite density in Brazilian dogs naturally infected by Leishmania (Leishmania) chagasi.

Reis AB, Teixeira-Carvalho A, Vale AM, Marques MJ, Giunchetti RC, Mayrink W, Guerra LL, Andrade RA, Corrêa-Oliveira R, Martins-Filho OA. Reis AB, et al. Vet Immunol Immunopathol. 2006 Aug 15;112(3-4):102-16. doi: 10.1016/j.vetimm.2006.02.001. Epub 2006 Apr 18. Vet Immunol Immunopathol. 2006. PMID: 16621021

10

FML vaccine against canine visceral leishmaniasis: from second-generation to synthetic vaccine.

Palatnik-de-Sousa CB, Barbosa Ade F, Oliveira SM, Nico D, Bernardo RR, Santos WR, Rodrigues MM, Soares I, Borja-Cabrera GP. Palatnik-de-Sousa CB, et al. Expert Rev Vaccines. 2008 Aug;7(6):833-51. doi: 10.1586/14760584.7.6.833. Expert Rev Vaccines. 2008. PMID: 18665780

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

383 results

Results by year